These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1035 related articles for article (PubMed ID: 3754580)

  • 21. Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain.
    Norman AB; Creese I
    Mol Pharmacol; 1986 Aug; 30(2):96-103. PubMed ID: 3755499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Irreversible binding of acetylethylcholine mustard to cardiac cholinergic muscarinic receptors.
    Baker SP; Posner P
    Mol Pharmacol; 1986 Nov; 30(5):411-8. PubMed ID: 3773882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of muscarinic receptor binding by guanine nucleotides and N-ethylmaleimide.
    Ehlert FJ; Roeske WR; Yamamura HI
    J Supramol Struct; 1980; 14(2):149-62. PubMed ID: 7230804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. (+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease.
    Fisher A; Brandeis R; Karton I; Pittel Z; Gurwitz D; Haring R; Sapir M; Levy A; Heldman E
    J Pharmacol Exp Ther; 1991 Apr; 257(1):392-403. PubMed ID: 2019998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Irreversible and quaternary muscarinic antagonists discriminate multiple muscarinic receptor binding sites in rat brain.
    Norman AB; Eubanks JH; Creese I
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1116-22. PubMed ID: 2703964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
    Gillard M; Waelbroeck M; Christophe J
    Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of muscarinic cholinergic receptor affinity for antagonists in rat heart.
    Martin MW; Smith MM; Harden TK
    J Pharmacol Exp Ther; 1984 Aug; 230(2):424-30. PubMed ID: 6379149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced high-affinity agonist binding at the M(1) muscarinic receptor in Alzheimer's disease brain: differential sensitivity to agonists and divalent cations.
    Ladner CJ; Lee JM
    Exp Neurol; 1999 Aug; 158(2):451-8. PubMed ID: 10415152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Light microscopic autoradiographic localization of [3H]pirenzepine and [3H](-)quinuclidinyl benzilate binding in human stellate ganglia.
    Yamamura HI; Watson M; Wamsley JK; Johnson PC; Roeske WR
    Life Sci; 1984 Aug; 35(7):753-7. PubMed ID: 6547993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. On the muscarinic receptors in the urinary bladder and the putative subclassification of muscarinic receptors.
    Nilvebrant L
    Acta Pharmacol Toxicol (Copenh); 1986; 59 Suppl 1():1-45. PubMed ID: 3524114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potency ratio for the inhibition of 3H-QNB and 3H-cis-methyldioxolane binding predicts agonist or antagonist activity on muscarinic receptors.
    Moret C; Pastrie I; Briley M
    Methods Find Exp Clin Pharmacol; 1988 Oct; 10(10):619-21. PubMed ID: 3236936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pirenzepine distinguishes between muscarinic receptor-mediated phosphoinositide breakdown and inhibition of adenylate cyclase.
    Gil DW; Wolfe BB
    J Pharmacol Exp Ther; 1985 Mar; 232(3):608-16. PubMed ID: 2579230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [3H]AF-DX 116 labels subsets of muscarinic cholinergic receptors in rat brain and heart.
    Wang JX; Roeske WR; Gulya K; Wang W; Yamamura HI
    Life Sci; 1987 Oct; 41(14):1751-60. PubMed ID: 3657382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The differential loss of [3H]pirenzepine vs [3H] (-) quinuclidinylbenzilate binding to soluble rat brain muscarinic receptors indicates that pirenzepine binds to an allosteric state of the muscarinic receptor.
    Roeske WR; Venter JC
    Biochem Biophys Res Commun; 1984 Feb; 118(3):950-7. PubMed ID: 6546685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The binding of a 2-chloroethylamine derivative of oxotremorine (BM 123) to muscarinic receptors in the rat cerebral cortex.
    Ehlert FJ; Jenden DJ
    Mol Pharmacol; 1985 Aug; 28(2):107-19. PubMed ID: 3839562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differentiation of muscarinic cholinergic receptor subtypes in human cortex and pons: implications for anti-motion sickness therapy.
    McCarthy BG; Peroutka SJ
    Aviat Space Environ Med; 1988 Jan; 59(1):63-6. PubMed ID: 3355470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The biphasic response of muscarinic cholinergic receptors in cultured heart cells to agonists. Effects on receptor number and affinity in intact cells and homogenates.
    Galper JB; Dziekan LC; O'Hara DS; Smith TW
    J Biol Chem; 1982 Sep; 257(17):10344-56. PubMed ID: 7107608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rat cardiac muscarinic receptors. I. Effects of guanine nucleotides on high- and low-affinity binding sites.
    Waelbroeck M; Robberecht P; Chatelain P; Christophe J
    Mol Pharmacol; 1982 May; 21(3):581-8. PubMed ID: 7110116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterogeneity of binding of muscarinic receptor antagonists in rat brain homogenates.
    Lee JH; el-Fakahany EE
    J Pharmacol Exp Ther; 1985 Jun; 233(3):707-14. PubMed ID: 3839264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacologic characterization and functional role of muscarinic autoreceptors in the rabbit striatum.
    James MK; Cubeddu LX
    J Pharmacol Exp Ther; 1987 Jan; 240(1):203-15. PubMed ID: 3806384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 52.